Clinical Report: Closing the Genomic Gap in Rare Disease

Overview

Revise to emphasize the urgency of equitable access and the role of long-read sequencing in improving diagnostic outcomes.

Background

Rare diseases affect over 300 million people globally, yet many remain undiagnosed due to limited access to advanced genomic testing. The disparity in access to genomic technologies can lead to prolonged diagnostic odysseys, impacting clinical care and patient outcomes. Understanding the genetic basis of these diseases is crucial for effective management and treatment.

Data Highlights

Key Findings

Clinical Implications

Detail specific actions healthcare providers can take to promote equitable access and the advantages of long-read sequencing.

Conclusion

Highlight systemic barriers and provide clear recommendations for improving access to genomic testing.

References

1. Ryan Taft, Genetic Alliance/iHope Network, 2026 -- Closing the Genomic Gap in Rare Disease
2. Stacy Musone, PacBio, 2026 -- Can Genomics Solve Rare Diseases?
3. Unlocking Hidden RNA Signals, 2026 -- Unlocking Hidden RNA Signals
4. Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay: Clinical Report, 2025 -- AAP Guidelines
5. the pathologist — Digital Twins for Rare Diseases
6. WHO publishes new global analysis revealing major equity gaps in human genomics research
7. Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay: Clinical Report
8. National Rapid Genome Sequencing in Neonatal Intensive Care | Pediatrics | JAMA Network Open | JAMA Network